
Recombinant Human Insulin-Like Growth Factor I (rhIGF-I) and rhIGF-I/rhIGF-Binding-Protein-3: New Growth Treatment Options?
Keywords: اداره غذا و داروی ایالات متحده; ALS; Acid labile subunit; GH; Growth hormone; GHD; GH deficient; GHRD; GH receptor deficient; IGFBP; IGF-binding proteins; IGF-I; Insulin-like growth factor I; rhIGF-I; Recombinant IGF-I; SDS; Standard deviation score; FDA; US Food and Drug Administration